http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012003145-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a60d2b8587fe33a53a65a02a13a55cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
filingDate 2011-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_864db741c088246b5e24b14bed0250a0
publicationDate 2012-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012003145-A3
titleOfInvention Therapeutic agents for ocular hypertension
abstract This invention provides well defined 6-alkyl or hydroxyalkyl-1-naphthamide or quinoline compounds for treating glaucoma or ocular hypertension.
priorityDate 2010-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4221815-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004022525-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5643957-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2604560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4207341-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0061631-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003073357-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1449586-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4238506-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226699186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226699187
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66667771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236070653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID239490608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5150145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66667772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229027386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87097467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21903993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70451296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226699188

Total number of triples: 49.